Physician profile
John D Willer
NPI 1255383212
$4,173.43
in general payments reported to CMS, 2019-2025
22 companies · $245 in 2025
The $245 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $629 · 2020: $356 · 2021: $328 · 2022: $1,702 · 2023: $618 · 2024: $296 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,159.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $1,580.25 | 2021-2022 | |
| Merz North America, INC. | $364.67 | 2020-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $328.19 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $316.84 | 2019-2024 | Eylea Hd, Eylea |
| Bausch & Lomb Americas INC. | $260.07 | 2022-2024 | Vyzulta, Miebo, Lotemax Sm |
| Johnson & Johnson Surgical Vision, INC. | $257.53 | 2019-2025 | Tecnis Iol, Veritas Vision System |
| Carl Zeiss Meditec USA, INC. | $168.93 | 2023-2024 | |
| Rayner Intraocular Lenses Limited | $152.78 | 2025 | Rayone Aspheric, Rayone Emv, Rayner Cataract Set 1 |
| Harrow Eye, LLC | $124.72 | 2023 | Iheezo |
| New World Medical,INC. | $98.18 | 2022-2023 | |
| Abbvie INC. | $91.38 | 2022-2024 | Durysta, Botox |
| Amgen INC. | $72.55 | 2024-2025 | Tepezza |
| Allergan, INC. | $57.68 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $55.49 | 2019 | |
| Glaukos Corporation | $49.15 | 2019-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivantis, INC | $46.04 | 2019 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $32.70 | 2024 | Xdemvy |
| Ani Pharmaceuticals, INC. | $25.20 | 2025 | Purified Cortrophin Gel |
| Novartis Pharmaceuticals Corporation | $18.25 | 2021 | |
| Dusa Pharmaceuticals, INC. | $17.25 | 2019 | |
| Aerie Pharmaceuticals, INC. | $16.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Willer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.